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Abstract
Background: The prevalence of metabolic syndrome (MS) has been increasing in China in recent years. The aim of this 
study is to estimate and compare the prevalence of MS among Chinese adults in Shanghai, one of the most economic 
developed areas in China, using definitions proposed by World Health Organization (WHO), National Cholesterol 
Education Program Adult Treatment Panel (modified ATP III) and International Diabetes Federation (IDF).
Methods: This cross-sectional study included 5,584 adults at age 20-79 randomly selected from Pudong New Area of 
Shanghai, China, through a three-stage sampling. All participants were interviewed in-person between April and July 
of 2008 to collect information on demographic and lifestyle characteristics. At the interview, anthropometry and blood 
pressure were measured and bio-specimens were collected.
Results: The prevalence estimates for the MS increased with age for each definition in men and women, but the 
estimates varied greatly between the definitions and by sex. The prevalence of the MS was higher in men (20.2%) than 
in women (18.7%) using WHO definition but this sex difference was reversed when using the modified ATP III (28.4% for 
men vs. 35.1% for women) and the IDF (15.9% for men vs. 26.7% for women) criteria. The most common metabolic 
disorder in this population was dyslipidaemia, regardless of the definition used. Substantial agreement, estimated 
using the kappa statistic, was found between the modified ATP III and IDF definition, whereas the lowest agreement 
was observed between the WHO and ATP III criteria.
Conclusions: The MS is highly prevalent among Chinese adults in Pudong New Area of Shanghai and the most 
prevalent component was dyslipidemia. These findings underscore the importance of prevention and control efforts 
for the MS in this area and the need for a unified predictive definition for the syndrome for use by clinical practitioners 
and public health agencies.
Background
The metabolic syndrome (MS) is a cluster of the most
dangerous risk factors for type 2 diabetes mellitus and
cardiovascular disease (CVD), including abdominal obe-
sity, hypertension, hyperglycemia and dyslipidemia.
When these metabolic abnormalities occur in the same
individual they confer an additional cardiovascular risk
above and beyond the contribution of the individual com-
ponents [1,2]. It is estimated that the risk from the MS for
major cardiovascular events is approximately twice as
high as for those with the syndrome compared to those
without it, and the risk for type 2 diabetes is around five-
fold greater for those with the MS [2-4].
The MS is becoming epidemic around the world and
the prevalence of the MS has been estimated to be more
than 20%. The high prevalence of the MS has been
reported not only in developed countries [5-7] but also in
developing regions [8,9], including China [10-13]. China
has experienced a remarkable economic expansion in the
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past three decades, and Pudong New Area of Shanghai is
one of the most economically active areas in the country.
This area of Shanghai has experienced a rapid nutrition
transition characterized by an increasingly sedentary life-
style and substantial dietary changes (e.g., increasingly
energy-density) [14], as well as a dramatic aging of the
population [15]. These changes are likely to have contrib-
uted to a high prevalence of the MS and increased risk for
type 2 diabetes, CVD and premature death. In order to
evaluate and predict the burden of CVD and other
chronic diseases in this area, population-based estimates
of the prevalence of the MS are needed.
So far, however, there has been no definition of the MS
accepted universally. Currently, several definitions of the
MS have been proposed for use, and each definition has a
slightly different emphasis. While the one proposed by
World Health Organization takes insulin resistance as a
required component [16], the modified ATP III criteria
treat the five components equally [17]. The IDF defini-
tion, on the other hand, puts an emphasis on central obe-
sity [18]. Due to the lack of internationally agreed-upon
criteria to define the condition, the prevalence of the MS
has varied widely across different studies. Comparisons
between the prevalence of the MS using these definitions
may help better understand the characteristics of meta-
bolic disorder among Chinese adults and facilitate inter-
ventions to prevent the MS and subsequent development
of CVD.
In this study, we estimated and compared the preva-
lence of the MS by applying the three definitions of the
condition in a representative sample of the residents in
Pudong New Area of Shanghai, China.
Methods
Participants of the study
This cross-sectional study was conducted from April to
July of 2008 among permanent residents of Pudong New
Area of Shanghai, China, who had lived in the area for 5
years or more. A total of 6,387 eligible adults (20-79 yrs)
were randomly selected from the area using a three-stage
sampling design. Firstly, all 30 streets in this area were
classified into three groups (each with 10 streets) accord-
ing to the residents' average social economic status [14]
a n d  1 2  s t r e e t s  ( 4  f r o m  e a c h  g r o u p )  w e r e  r a n d o m l y
selected. Then, a total of 34 communities, which hold
about 71,000 eligible residents, were randomly selected
from the 783 communities in the selected streets. The
expected number of participants in each community was
calculated as 9.0% of its eligible population. Finally, a
house number was randomly selected in each community
as the first family interviewed. All eligible subjects in the
s e l e c t e d  f a m i l i e s  w e r e  r e c r u i t e d .  P r e g n a n t  w o m e n  a n d
physically or mentally disabled persons were excluded
from the survey. Of the 6,387 eligible adults contacted,
5,584 were interviewed and donated blood and urine
samples, yielding a response rate of 87.4%. Of these par-
ticipants, 2,477 were male and 3,107 were female, and 804
non-participants (12.6%) declined to be interviewed for
miscellaneous reasons. The study was approved by Fudan
University Institutional Review Board (IRB00002408,
FWA00002399).
Data collection
After obtaining written consent, a structured in-person
interview was conducted by trained interviewers to elicit
information about demographic factors, diagnosis of
hypertension, diabetes and hyperlipidemia, tobacco and
alcohol use, physical activity, and family history of hyper-
tension and diabetes. At the interview, each participant
was also measured for his/her blood pressure, body
weight, standing height, and circumference of the waist
and hip by trained staff. Blood pressure (BP) was mea-
sured on the right arm in the sitting position using stan-
dard mercury sphygmomanometer after at least 5
minutes of rest. The first and fifth Korotkoff sounds were
recorded. Body height was measured to the nearest 0.1
cm by using a stadiometer. Girth measurements,
recorded to the nearest 0.1 cm, were taken with a cloth
tape. Waist circumference (WC) was measured at the
midline between the lower border of the ribs and the iliac
crest (usually at a level of 2.5 cm above the umbilicus) in
the horizontal plane after a normal expiration. Hip cir-
cumference was defined as the maximum girth reading
between waist and thigh. Body weight was measured with
electronic scales to the nearest 0.1 kg. Two measurements
were taken, with tolerances of <5 mmHg for blood pres-
sure, <1 cm for height and circumference, and <1 kg for
weight. A third measurement was taken if the difference
between the first two exceeded the tolerance. The mean
of the replicates was used in the following analyses. Body
mass index (BMI: weight in kilograms divided by height
in meters squared, kg/m2) and waist-to-hip circumfer-
ence ratio (WHR) were calculated using the direct mea-
surements.
Laboratory measurements
All participants were asked to provide 10 ml fasting blood
and 50 ml morning void urine for biochemical analysis in
Shanghai Second People's Hospital. An automatic Bio-
chemical Analyzer (HITACHI 7170A, Hitachi, Ltd,
T okyo, Japan) was used to measure the levels of fasting
plasma glucose (FPG), triglycerides (TG), high-density
lipoprotein cholesterol (HDL-C), low-density lipoprotein
cholesterol (LDL-C) and total cholesterol (TC), as well as
urinary concentrations of creatinine and albumin by
using enzymology or immunoradiometry methods. Qual-Xu et al. BMC Public Health 2010, 10:246
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ity control of the assays was assessed internally and exter-
nally. The interassay coefficient of variation was <1.5% for
FPG, <1.6% for TG, <3.0% for TC, <2.9% for HDL-C,
<1.6% for LDL-C, <7.0% for urinary album, and <2.1% for
urinary creatinine.
Definitions of the metabolic syndrome
The WHO criteria [16] for the MS required the presence
of diabetes mellitus or impaired fasting plasma glucose
(FPG ≥ 5.6 mmol/L) and at least two of the following
components: 1) diagnosed with hypertension or blood
pressure: ≥ 140/90 mmHg; 2) dyslipidemia: TG ≥ 1.695
mmol/L or HDL-C ≤ 0.9 mmol/L (male), ≤ 1.0 mmol/L
(female); 3) central obesity: WHR > 0.90 (male); > 0.85
(female), or BMI ≥ 30 kg/m2; or 4) microalbuminuria: uri-
nary albumin to creatinine ratio (ACR) ≥ 30 mg/g.
The modified ATP III definition of the MS [17]
required the presence of at least 3 or more of the follow-
ing 5 components: 1) elevated WC: ≥ 90 cm (male), ≥ 80
cm (female); 2) elevated TG: > 150 mg/dL (1.695 mmol/
L); 3) reduced HDL-C: < 1.036 mmol/L (male), < 1.295
mmol/L (female); 4) hypertension or elevated BP: ≥ 130/
85 mmHg; or 5) diabetes or elevated FPG: ≥ 5.6 mmol/L.
The 2006 International Diabetes Federation (IDF) defi-
nition classified a person with the MS in the same way as
ATP III, but required the presence of central adiposity
(elevated WC) as an essential component [18].
Statistical analysis
Statistical analysis was conducted using SAS (version 8.1;
SAS Institute, Cary, NC). Chi-square and student t tests
were used to compare the difference between categorical
and numeric variables. Age-standardized prevalence of
the MS was calculated based on the age distribution of
the standard world population. Logistic regression mod-
els were fit to evaluate the association of individual meta-
bolic abnormalities with the MS. In addition, kappa
statistics were calculated to determine the level of agree-
ment between the three MS definitions. P values < 0.05
were considered statistically significant.
Results
Measured metabolic characteristics of the study 
population
Table 1 presents the measured metabolic characteristics
in our population. Compared to women, men had a sig-
nificantly higher WC, WHR, BMI, higher systolic and
diastolic BP and higher levels of FPG and TG. Men also
had lower levels of HDL-C and ACR than women. The
differences between men and women in prevalence of
elevated BMI or WC were not significant, but men had a
higher prevalence of elevated BP, FPG and TG, while
women had a higher prevalence of low HDL-C and ele-
vated ACR (Table 1).
Sex and age-specific prevalence of the MS in the study 
population
The prevalence of the MS was observed to increase with
increasing age in both sexes by either one of the three
definitions. It is of note that the age-specific prevalence
was higher in men than in women in early adulthood
(before age of 65 according to WHO definition and at age
of 40 using ATP III and IDF criteria) but appeared lower
during elderly period (Table 2). The MS was more com-
mon in men (20.2%) than in women (18.7%) using WHO
definition but was otherwise according to modified ATP
III (28.4% for men vs. 35.1 for women) and IDF (15.9% for
men vs. 26.7% for women) criteria.
Prevalence of individual metabolic abnormalities in the 
study population
The prevalence of individual metabolic abnormalities is
presented in Table 3. According to WHO criteria, dyslipi-
demia, i.e. elevated TG or reduced HDL-C, was the most
common metabolic abnormality in both men (56.9%) and
women (47.8%), followed by central obesity, elevated
FPG, raised BP and presence of microalbuminuria.
Among the five metabolic abnormalities defined by mod-
ified ATP III or IDF criteria, elevated TG also ranked first
in both sexes (59.2% for men and 49.7% for women), fol-
lowed by elevated BP (49.0% for men and 44.8% for
women), elevated FPG (36.7% for men and 32.2%),
increased WC (22.1% for men and 38.5 for women) and
reduced HDL-C (11.1% for men and 19.3% for women).
In this population, the present of 1 or 2 metabolic abnor-
malities was most common in both men and women.
Prevalence of the MS among subjects with a certain 
metabolic abnormality
Figure 1 shows the prevalence of MS estimated by each
definition in all participants and among subjects with a
specific metabolic abnormality. The prevalence of the MS
was 40.0% for the men and 34.5% for the women with ele-
vated WC using WHO definition, but the prevalence esti-
mated was substantially greater when using the modified
ATP III (71.6%) and IDF criteria (69.3%). Among the sub-
jects with high BP, only 32.5% of the men and 34.1% of the
women had the MS using the WHO definition whereas
50.0% of the men and 63.2% of the women were classified
as such according to the modified ATP III definition. Dif-
ference in the prevalence of MS was also observed among
subjects having other individual metabolic abnormalities.
Association of individual metabolic abnormalities with the 
MS
We also examined the association of the individual meta-
bolic abnormalities with the MS. Subjects with any one
metabolic disorder were more likely to be diagnosed with
the MS by modified ATP III definition (Table 4). Microal-Xu et al. BMC Public Health 2010, 10:246
http://www.biomedcentral.com/1471-2458/10/246
Page 4 of 11
buminuria, one component of the WHO criteria, was
strongly associated with the condition in both sexes, but
was not significantly related to the MS in men using the
definitions of the ATP III or IDF. Interestingly, regardless
of the definition used, subjects with elevated TG were
most likely to be diagnosed with the MS, with odds ratios
(OR) being 7.6, 15.9 and 5.1 for men and 7.3, 16.5 and 7.7
for women under WHO, ATPIII and IDF definition,
respectively, after adjusting for age, BMI, alcohol con-
sumption, cigarette smoking and exercise.
Agreement between the three MS definitions
Figure 2 shows the overall prevalence of the MS by WHO,
modified ATP III and IDF criteria. Nine percent of men
and 13.3% of women were consistently classified as hav-
ing the MS by each definition and 68.6% of men and
64.1% of women were classified as being free from the MS
consistently. The level of agreement between each two
definitions was modest, with kappa value ranging from
0.382 to 0.806 (Table 5). Agreement between modified
ATP III and IDF criteria was substantial with a kappa of
0.647 for men and 0.806 for women. All subjects classi-
fied with the MS by the IDF definition were also classified
this way by the ATP III criteria. The lowest level of agree-
ment was between the WHO and IDF definitions in both
men (κ = 0.382) and women (κ = 0.469).
Discussion
In this representative sample of adults whose age and sex
distribution was similar to that in Pudong New Area of
Table 1: Measured metabolic characteristics of the selected Chinese adults in Pudong New Area of Shanghai, China
Characteristics Male (N = 2477) Female (N = 3107) P value
WC
Mean ± SD 83.9 ± 9.2 78.3 ± 9.4 <0.0001
≥ 90 cm for male 22.1
≥ 80 cm for female 38.5 <0.0001
BMI
Mean ± SD 24.1 ± 3.3 23.8 ± 3.5 <0.0001
≥ 30 kg/m2 4.5 5.3 0.16
WHR
Mean ± SD 0.88 ± 0.06 0.83 ± 0.07 <0.0001
>0.90 for male 38.3
>0.85 for female 37.9 0.93
Systolic BP
Mean ± SD 128 ± 16.1 126 ± 19.6 <0.0001
≥ 130 mmHg 40.3 37.5 0.03
Diastolic BP
Mean ± SD 81 ± 9.5 80 ± 10.1 <0.0001
≥ 85 mmHg 27.0 24.6 0.05
FPG
Mean ± SD 5.8 ± 1.9 5.7 ± 1.6 0.0003
>5.6 mmol/l 35.9 31.4 0.0006
HDL-C
Mean ± SD 1.34 ± 0.26 1.48 ± 0.27 <0.0001
<1.036 mmol/l for male 11.1
<1.295 mmol/l for female 25.8 <0.0001
TG
Mean ± SD 2.4 ± 2.1 2.1 ± 1.7 0.0001
>1.695 mmol/l 56.5 47.0 <0.0001
Urinary ACR
Mean ± SD 2.0 ± 9.2 2.8 ± 11.1 <0.0001
≥ 30 mg/g 0.8 1.6 0.0035
P value for t-test (continuous variables) or χ2 test (categorical variables).Xu et al. BMC Public Health 2010, 10:246
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Shanghai, China [19], we found that the MS was highly
prevalent. Using the modified criteria of ATP III for the
MS the prevalence was 28.4% for men and 35.1% for
women. The overall and age-specific prevalence of the
MS in this population were much higher than the general
levels of Chinese adults in 1992 and 2000-01 [20,21], and
were similar to those in other economically developed
areas in China [11,13]. In fact, the prevalence of the MS
was comparable to those in developed countries [5,22].
Consistent with the results from studies in other popu-
lations [5,13,22], the prevalence of the MS increased with
age in both sexes in our study. We observed a wide dis-
crepancy between the crude and age-standardized preva-
lence of the MS, indicating that the increasing proportion
of older adults in the population has contributed much to
the overall prevalence of the MS in this area. The number
of adults at age 60+ years in Shanghai reached 3.0 million
in 2008, and they account for more than 20 percent of all
residents in the city [23]. Interestingly, in early adulthood
the age-specific prevalence was higher in men than in
women but this pattern was reversed among older adults.
The age-specific prevalence pattern we observed was
consistent with that in a Japanese population [24], but dif-
fered from several other previous studies, in which a
Table 2: Sex and age-specific prevalence of the MS according to WHO, modified ATP III and IDF definition among selected 
Chinese adults in Pudong New Area of Shanghai, China
No. of Subjects WHO criteria ATP III criteria IDF criteria
No. of MS % No. of MS % No. of MS %
Male
2477 498 20.2(15.3) 696 28.4(22.7) 391 15.9(13.8)
20- 141 3 2.1 10 7.1 9 6.4
25- 124 6 4.9 17 14.1 14 11.6
30- 134 8 6.1 16 12.2 12 9.2
35- 142 22 15.8 26 18.7 17 12.2
40- 204 35 17.2 54 26.7 34 16.8
45- 314 55 17.5 74 23.7 38 12.2
50- 309 76 19.6 114 29.5 61 15.8
55- 348 85 24.6 117 33.9 61 17.7
60- 258 80 31.3 103 40.2 51 19.9
65- 162 51 31.7 68 42.5 38 23.8
70- 173 44 25.4 62 35.8 34 19.7
75- 88 33 37.5 35 40.2 22 25.3
Female
3107 575 18.7(12.3) 1078 35.1(25.0) 821 26.7(19.2)
2 0 -1 5 9 0 0 31 . 931 . 9
25- 176 3 1.8 15 8.8 14 8.2
30- 156 3 1.9 13 8.4 10 6.5
35- 186 8 4.4 33 17.9 28 15.2
40- 274 20 7.4 48 17.8 34 12.6
45- 395 59 15.0 113 28.8 83 21.1
50- 551 98 17.9 205 37.6 149 27.3
55- 468 123 26.5 210 45.2 172 37.0
60- 265 80 30.2 147 55.5 110 41.5
65- 189 59 31.9 96 52.5 71 38.8
70- 188 75 39.9 130 69.5 99 52.9
75- 100 47 47.5 65 65.7 48 48.5
In parentheses was the age-standardized prevalence of the MS according to age distribution of the world population.Xu et al. BMC Public Health 2010, 10:246
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higher age-specific prevalence of the MS was consistently
observed for women [5,10,11]. The explanation for this
finding is not immediately clear, and the pattern varied by
the definition employed. It is possible that the men in
Shanghai were at a higher risk of the MS than women,
and thus had a higher mortality from CVD and diabetes
in later adulthood. In addition, selection biases and
chance cannot be excluded. Notably, the cross-over point
of the sex specific prevalence estimates by age was much
later in life when the WHO definition was used (about
age 65), compared to the modified ATP III or IDF criteria
(about age 40). This may explain the higher overall preva-
lence of the MS in men using WHO but the higher preva-
lence estimates in women according to modified ATP III
and IDF criteria.
Another significant finding in this study is that dyslipi-
demia, particularly hypertriglyceridemia, is the most
common metabolic disorder in our population. This find-
ing is much different from those of a national estimate
from all of China [10], even after taking age differences
and the MS definitions used in the two studies into
account. The differences in MS components may be due
to differences in behavioral risk factors (i.e. diet or life-
style) rather than genetic susceptibility. The rapid "nutri-
tion transition" in Shanghai, characterized by a more
sedentary lifestyle and an energy-dense higher fat diet
may, at least in part, account for the higher prevalence of
Table 3: Prevalence of individual metabolic abnormalities among selected Chinese adults in Pudong New Area of 
Shanghai, China
Metabolic abnormalities Male (2477) Female (3107) Total (5583)
Number % Number % Number %
By WHO criteria
Impaired FPG or diabetes 903 36.7 992 32.2 1895 34.2
Central obesity 973 39.3 1224 39.4 2197 39.3
Elevated BP or hypertension 778 31.4 927 29.8 1705 30.5
Microalbuminuria 19 0.8 51 1.6 70 1.3
Hyperlipidemia 1409 56.9 1485 47.8 2894 51.8
No. of metabolic abnormalities
0 483 19.6 859 27.9 1342 24.2
1 682 27.7 791 25.7 1473 26.6
2 675 27.4 696 22.6 1371 24.8
3 455 18.5 495 16.1 950 18.2
4 161 6.5 226 7.3 387 7.0
5 4 0.2 13 0.4 17 0.3
By modified ATP III or IDF criteria
Increased WC 548 22.1 1196 38.5 1744 31.2
Elevated BP or hypertension 1213 49.0 1393 44.8 2606 46.7
Reduced HDL-C or use drug 272 11.1 795 25.8 1067 19.3
Elevated TG or use drug 1455 59.2 1532 49.7 2987 54.0
Impaired FPG or diabetes 903 36.7 992 32.2 1895 34.2
No. of metabolic abnormalities
0 418 17.0 667 21.7 1085 19.6
1 663 27.0 677 22.0 1340 24.2
2 676 27.6 652 21.2 1328 24.0
3 460 18.8 557 18.1 1017 18.4
4 206 8.4 385 12.5 591 10.7
5 30 1.2 136 4.4 168 3.0Xu et al. BMC Public Health 2010, 10:246
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hyperlipidemia in our population. This element of the
"nutrition transition" is a central contributor of hyperlipi-
demia [25] and may function as initiation factor for the
MS [26].
Importantly, the distinct characteristic of the metabolic
disorder in this population may indicate predictive value
of the MS for the risk of CVD and other chronic diseases
in the area. The definitions of the MS, either proposed by
WHO, ATP III or IDF, similarly focus on obesity, hyper-
tension, hyperglycaemia and dyslipidemia. The MS is
usually identified by the presence of at least 3 of 5 meta-
bolic abnormalities. It is thus plausible that the character-
istics of the MS vary across populations. For example,
blacks in the US are more likely than the whites to have
the clustering of obesity, hypertension and diabetes but
less likely to have either elevated TG or low HDL-C lev-
els, leading to a lower prevalence of the MS but higher
rates of diabetes and CVD in the blacks than in the whites
[27]. If it is true that dyslipidemia is less important in pre-
dicting the diabetes and CVD than other metabolic disor-
ders, as suggested by Sumner et al's [27], the fact that
dyslipidemia is the most common metabolic abnormality
in our population may indicate and account for the com-
parable prevalence of the MS but a lower incidence of
diabetes and CVD in Chinese adults than in their western
counterparts.
The level of agreement we observed among the three
definitions was modest and not surprisingly the preva-
lence of the MS was quite different according to each
individual definition employed. This finding is consistent
with previous studies conducted in Chinese adults
[13,21], and other populations [6,7,28-30]. Although
Figure 1 Prevalence of the MS according to WHO, modified ATP III and IDF criteria in all participants and the subjects with each individual 
metabolic abnormality.
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Table 4: Association of individual metabolic abnormalities with the MS among selected Chinese adults in Pudong New 
Area of Shanghai, China
Metabolic abnormalities MS by WHO MS by ATP III MS by IDF
No/Yes OR(95%CI) No/Yes OR(95%CI) No/Yes OR(95%CI)
Male
Impaired FPG or diabetes
No 1557/0 -- 1379/176 1.0 1413/142 1.0
Yes 405/498 -- 377/521 9.6(7.8-11.9) 648/250 3.5(2.8-4.4)
Central obesity (WC > 90 cm)
No 1632/279 1.0 1602/305 1.0 1907/0 --
Yes 329/219 3.9(3.1-4.8) 154/392 14.9(11.8-18.9) 154/392 --
Hypertension or elevated BP (sbp ≥ 130 or dbp ≥ 85 mmHg)
No 1143/107 1.0 1151/96 1.0 1170/77 1.0
Yes 819/391 4.1(3.2-5.2) 605/601 10.7(8.4-13.7) 891/315 5.1(3.9-6.7)
Microalbuminuria
No 1956/485 1.0 1748/687 1.0 2049/386 1.0
Yes 6/13 6.8(2.5-18.7) 8/10 2.4(0.9-6.1) 12/6 2.1(0.8-5.8)
Reduced HDL-C or use druga
No 1770/416 1.0 1681/502 1.0 1893/290 1.0
Yes 192/80 1.5(1.1-2.0) 75/195 9.9(7.2-13.8) 168/102 3.2(2.3-4.6)
Elevated TG or use druga
No 950/50 1.0 950/49 1.0 953/46 1.0
Yes 1009/446 7.6(5.5-10.4) 806/648 15.9(11.3-22.2) 1108/346 5.1(3.5-7.4)
Dyslipidemia (reduced HDL-C or elevated TG)a
No 1007/60 1.0 986/76 1.0 1001/61 1.0
Yes 955/438 7.4(5.5-10.0) 770/621 10.9(8.2-14.6) 1060/331 4.2(3.0-5.8)
Female
Impaired FPG or diabetes
No 2088/0 -- 1706/380 1.0 1757/329 1.0
Yes 417/575 -- 288/700 8.4(7.0-10.1) 495/493 3.9(3.3-4.7)
Central obesity (WC > 85 cm)
No 1427/166 1.0 1631/258 1.0 1889/0 --
Yes 778/409 4.0(3.3-4.9) 363/822 12.0(10.0-14.5) 363/822 --
Hypertension or elevated BP (sbp ≥ 130 or dbp ≥ 85 mmHg)
No 1590/103 1.0 1484/205 1.0 1515/174 1.0
Yes 915/472 4.9(3.8-6.2) 510/875 8.3(6.8-10.0) 737/648 5.3(4.3-6.5)
Microalbuminuria
No 2489/540 1.0 1983/1040 1.0 2235/788 1.0
Yes 16/35 7.8(4.0-15.3) 11/40 5.3(2.5-11.2) 17/34 4.1(2.2-7.8)
Reduced HDL-C or use druga
No 1951/333 1.0 1738/543 1.0 1841/440 1.0
Yes 553/241 2.3(1.8-2.8) 256/537 10.4(8.2-13.1) 411/382 4.0(3.2-5.0)Xu et al. BMC Public Health 2010, 10:246
http://www.biomedcentral.com/1471-2458/10/246
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68.6% of the men and 64.1% of the women were consis-
tently classified as being free of MS by all 3 definitions,
only 9.0% of men and 13.3% of women were consistently
classified with the MS by all three criteria. More than 20%
of the participants were classified differently using the
three definitions. In addition, the prevalence of the MS
varied greatly among the subjects with specific individual
metabolic abnormalities depending on the definition
employed. This reflects that the three definitions have
their own respective emphasis. The WHO definition
directly assigns greatest value to insulin resistance which
is usually indicated by impaired fasting glucose. In con-
trast, the modified ATP III and IDF definitions do not
employ insulin resistance as a required component based
on the assumption that the other four components of the
MS are linked to insulin resistance. However, significant
proportions of those with the four individual components
in our sample did not evidence of have insulin resistance
as indicted by the criteria employed. For example, there is
evidence suggesting no strong link between hypertension
and insulin resistance [31]. The phenomenon may explain
the discrepancy in the prevalence of the MS in the same
population estimated by three definitions. A single
worldwide definition of the MS would be desirable to
make comparisons between different populations easier
and for clinical, epidemiologic and surveillance purposes.
T h e r e  i s  a  n e e d  f o r  e x i s t i n g  c o h o r t  s t u d i e s  i n  A s i a  t o
explore the best and most predictive definition of the MS
and its components.
An important limitation of the present study is the
cross-sectional design. This fact limited our ability to
examine the most predictive MS definition for the risk of
Elevated TG or use druga
No 1485/62 1.0 1432/115 1.0 1440/107 1.0
Yes 1017/511 7.3(5.4-9.7) 562/965 16.5(12.9-21.2) 812/715 7.7(6.0-9.9)
Dyslipidemia (reduced HDL-C or elevated TG)a
No 1547/73 1.0 1456/161 1.0 1475/142 1.0
Yes 958/502 7.1(5.4-9.4) 538/919 12.1(9.7-15.2) 777/680 5.9(4.7-7.5)
OR: Adjusted for age as a continuous variable.
a additionally adjusted for BMI (as a continuous variable), cigarette smoking (Never/Ever), alcohol consumption (Never/Ever) and exercise 
(Never/ever).
Table 4: Association of individual metabolic abnormalities with the MS among selected Chinese adults in Pudong New 
Area of Shanghai, China (Continued)
Table 5: Agreement of WHO, modified ATP III and IDF criteria in identifying the MS among selected Chinese adults in 
Pudong New Area of Shanghai, China
WHO criteria κ 95%CI ATP III criteria κ 95%CI
+- +-
Male
ATP III criteria
+ 434 276 -- --
- 73 1670 0.617 0.611-0.622 -- -- --
IDF criteria
+ 220 177 397 0
- 287 1769 0.382 0.377-0.387 313 1743 0.647 0.643-0.652
Female
ATP III criteria
+ 553 532 -- --
- 27 1962 0.552 0.547-0.558 -- -- --
IDF criteria
+ 413 414 827 0
- 167 2080 0.469 0.464-0.474 258 1989 0.806 0.802-0.810
P < 0.01 for all κ statistics.Xu et al. BMC Public Health 2010, 10:246
http://www.biomedcentral.com/1471-2458/10/246
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diabetes, CVD and premature death among Chinese
adults. Moreover, the prevalence of the MS by WHO cri-
teria might be underestimated in this study because
impaired fasting glucose was used as the surrogate of
impaired glucose tolerance which is more common in
Chinese adults [32]. Finally, we cannot exclude problems
associated with selection bias from the study, although
our response rate to the study was quite high (89.4%). The
strengths of this study include the representative sample
population, large sample size, and our rigorously stan-
dardized methods for measuring the MS components.
Conclusion
In summary, this cross-sectional study shows that the MS
characterized with dyslipidemia is highly prevalent in
adult population in Pudong New Area of Shanghai,
China. The ongoing nutrition transition in this area and
the aging of the population may have caused and will
aggravate this problem in future years. Given the rela-
tively high prevalence estimates regardless of the defini-
tion used, there is a need for a unified definition of the
MS in Chinese adults that may guide prevention and
treatment efforts to fight against the growing MS epi-
demic in China.
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